Global Ontogenetic Market: Regional Insights
Based on geography, the global ontogenetic market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing burden of neurologic disorders and increase in use of ontogeny (as potential diagnostic tool) in the field of neuroscience. For instance, in case of Alzheimber's disease, optogenetics enables a more precise diagnosis of the neural activity of the brain. According to the Alzheimer's Association, over 6 million Americans of all ages have Alzheimer's. About 1 in 9 age 65 and older (10.7%) has Alzheimer's, while an estimated 6.5 million Americans age 65 and older were living with Alzheimer's in 2022. This in turn is driving the market growth.
Europe and Asia Pacific are also expected to witness significant growth in the global ontogeneticmarket due to the increase in adoption of various oncologic practices and rise in patient population in these regions. For instance, optogenetics can be used as potential tool for both the diagnosis and treatment of a variety of diseases, such as neurological diseases. According to the report published in July 2021 by the Public Health Foundation of India (PHFI), the burden of non-communicable neurological disorders is increasing in India mainly due to ageing of the population. India's elderly population (aged 60 and above) is expected to touch 194 million in 2031 from 138 million in 2021, according to the National Statistical Office (NSO)’s Elderly in India 2021 report.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients